Christopher Sarno, MD
Otolaryngology · Kittery, MENPI 1326138041
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,844 of the $2,305 with a category attached, or 80.0%. 14 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 52.2% of the total. 2025 is the largest year on record at $1,104, 9.8 times the $113 reported in 2019.
Across 63 payments — averaging $36.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$1K
- Sanofi$320
- GSK$243
- Regeneron Healthcare Solutions, Inc.$166
- Intersect ENT, Inc.$103
- Aerin Medical Inc.$51
- plus $220 from 8 others
What the payments were for
- Travel & lodging$44119%
- Food & beverage$1,84480%
- Education$211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 14 | $1,203 |
| Sanofi | 14 | $320 |
| GSK | 11 | $243 |
| Regeneron Healthcare Solutions, Inc. | 8 | $166 |
| Intersect ENT, Inc. | 3 | $103 |
| Aerin Medical Inc. | 3 | $51 |
| Phathom Pharmaceuticals, Inc. | 2 | $42 |
| Novartis | 2 | $38 |
| Acclarent, Inc | 1 | $36 |
| Paratek Pharmaceuticals, Inc. | 1 | $32 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Olympus America Inc. | 1 | $20 |
| Stryker | 1 | $18 |
| AstraZeneca | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$972
How this compares
$2,305 in reported general payments places this provider in the 75th percentile of 42 otolaryngology providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 12 | $53,123 |
| Omeprazole | 266 | $2,712 |
| Famotidine | 272 | $2,507 |
| Ipratropium Bromide | 57 | $2,444 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 15 | $1,091 |
| Fluticasone Propionate | 33 | $805 |
| Azelastine Hcl | 14 | $685 |
| Nortriptyline Hcl | 15 | $350 |
| Pantoprazole Sodium | 25 | $320 |
| Mometasone Furoate | 12 | $151 |
| Mupirocin | 28 | $145 |
| Cephalexin | 30 | $134 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Kittery
- Brett RankinKittery$732
- John StallmanKittery$216
- Jeffrey BedrosianPortland$727K
- Peter O'ConnorBrunswick$27K
- Stephen MaturoPortland$14K
- Elizabeth PearceFalmouth$5K
- William ReedScarborough$4K
- Brian CusickAugusta$4K
- Rebecca HarveyScarborough$4K
- Jay RaisenScarborough$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.